Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MDGL | NBIX | SMMT | ||
| Company | Madrigal Pharmaceuticals Inc | Neurocrine Bioscienc | Summit Therapeu ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 546.78 | 178.87 | 15.18 | ||
| High | 552.71 | 180.28 | 15.70 | ||
| Low | 536.45 | 171.81 | 14.65 | ||
| Latest | 537.59 | 172.69 | 14.74 | ||
| Change | -9.20 | -6.36 | +0.11 | ||
| % Change | -1.68% | -3.55% | +0.75% | ||
| Volume | 310,893 | 1,191,671 | 4,249,016 | ||
| 20-Day Average Volume | 431,800 | 1,142,669 | 3,943,941 | ||
| Previous Close | 546.79 | 179.05 | 14.63 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 535.85 | 172.61 | 14.78 | ||
| 20-Day Raw Stochastic | 50.54% | 54.94% | 51.30% | ||
| 20-Day Relative Strength | 53.29 | 56.56 | 47.23 | ||
| Weighted Alpha | +61.54 | +36.31 | -39.22 | ||
| Today's Opinion | 88% Buy | 100% Buy | 100% Sell | ||
| Previous Opinion | 88% Buy | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 24% Buy | 88% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.30% since 07/15/26 | +0.37% since 07/15/26 | -2.19% since 07/15/26 | ||
| Low | 532.64 on 07/16/26 | 169.01 on 07/16/26 | 13.36 on 07/17/26 | ||
| High | 560.09 on 07/17/26 | 180.28 on 07/22/26 | 15.70 on 07/22/26 | ||
| 1-Month | |||||
| %Chg | +4.82% since 06/22/26 | +6.85% since 06/22/26 | +3.22% since 06/22/26 | ||
| Low | 505.05 on 06/25/26 | 160.42 on 06/23/26 | 13.36 on 07/17/26 | ||
| High | 569.44 on 07/09/26 | 181.18 on 07/10/26 | 16.05 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | +1.60% since 04/22/26 | +31.64% since 04/22/26 | -40.03% since 04/22/26 | ||
| Low | 445.20 on 06/03/26 | 126.49 on 04/29/26 | 12.55 on 06/10/26 | ||
| High | 569.44 on 07/09/26 | 181.18 on 07/10/26 | 24.72 on 04/23/26 | ||
| 6-Month | |||||
| %Chg | +7.94% since 01/22/26 | +25.71% since 01/22/26 | -15.14% since 01/22/26 | ||
| Low | 416.21 on 03/03/26 | 122.14 on 02/12/26 | 12.55 on 06/10/26 | ||
| High | 572.20 on 03/26/26 | 181.18 on 07/10/26 | 29.23 on 04/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,606,785 | 18,003,478 | 11,355,265 | ||
| Shares Outstanding, K | 23,056 | 100,550 | 776,163 | ||
| Annual Sales | 958,400,000 | 2,860,500,000 | 0 | ||
| Annual Net Income | -288,280,000 | 478,600,000 | -1,079,590,000 | ||
| Last Quarter Sales | 311,340,000 | 814,500,000 | 0 | ||
| Last Quarter Net Income | -94,390,000 | 197,900,000 | -189,420,000 | ||
| 60-Month Beta | -1.05 | 0.39 | -1.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -3.25 on 05/06/26 | 1.94 on 05/05/26 | -0.24 on 04/30/26 | ||
| Earnings Date | 07/30/26 | 07/30/26 | 07/23/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.12 | 0.00 | ||